![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 8
2022
Zellmer, Johannes; Yen, Hsi-Yu; Kaiser, Lena; Gildehaus, Franz Josef; Böning, Guido; Steiger, Katja; Hacker, Marcus; Bartenstein, Peter; Todica, Andrei; Haug, Alexander R. und Ilhan, Harun
(2022):
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors.
In: Biomedicines, Bd. 10, Nr. 12
[PDF, 2MB]
2020
Zellmer, Johannes; Yen, Hsi-Yu; Kaiser, Lena; Mille, Erik; Gildehaus, Franz Josef; Boening, Guido; Steiger, Katja; Hacker, Marcus; Bartenstein, Peter; Todica, Andrei; Haug, Alexander R. und Ilhan, Harun
(2020):
Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [Lu-177]Lu-DOTA-TATE in Lewis rats.
In: EJNMMI Research, Bd. 10, Nr. 1, 41
2018
Hartenbach, Markus; Weber, Stefan; Pilz, Magdalena; Hartenbach, Sabrina; Zacherl, Mathias J.; Paprottka, Philipp M.; Tiling, Reinhold; Bartenstein, Peter; Hacker, Marcus; Haug, Alexander R. und Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma.
In: Clinical Nuclear Medicine, Bd. 43, Nr. 7: S. 477-481
[PDF, 288kB]
ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma.
In: Clinical Nuclear Medicine, Bd. 43, Nr. 7: S. 477-481
[PDF, 288kB]
2017
Sabet, Amir; Haug, Alexander R.; Eiden, Collin; Auernhammer, Christoph J.; Simon, Birgit; Bartenstein, Peter; Biersack, Hans J. und Ezziddin, Samer
(2017):
Efficacy of peptide receptor radionuclide therapy with Lu-177-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis.
In: American Journal of Nuclear Medicine and Molecular Imaging, Bd. 7, Nr. 2: S. 74-83
2016
Ilhan, Harun; Wang, Hao; Gildehaus, Franz J.; Wängler, Carmen; Herrler, Tanja; Todica, Andrei; Schlichtiger, Julia; Cumming, Paul; Bartenstein, Peter; Hacker, Marcus und Haug, Alexander R.
(2016):
Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathy.
In: EJNMMI Research, Bd. 6, 64
[PDF, 3MB]
Klingenstein, Annemarie; Müller-Lisse, Gerd Ullrich; Haug, Alexander R.; Garip-Kuebler, Aylin; Miller, Christina V. und Hintschich, Christoph R.
(2016):
Combined positron emission tomography/computed tomography (PET/CT) for imaging of orbital tumours and tumours extending into the orbit.
In: British Journal of Ophthalmology, Bd. 100, Nr. 10: S. 1403-1408
[PDF, 397kB]
Fendler, Wolfgang P.; Lechner, Hanna; Todica, Andrei; Paprottka, Karolin J.; Paprottka, Philipp M.; Jakobs, Tobias F.; Michl, Marlies; Bartenstein, Peter; Lehner, Sebastian und Haug, Alexander R.
(2016):
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.
In: Journal of Nuclear Medicine, Bd. 57, Nr. 4: S. 517-523
2014
Koch, Walter; Auernhammer, Christoph J.; Geisler, Julia; Spitzweg, Christine; Cyran, Clemens C.; Ilhan, Harun; Bartenstein, Peter und Haug, Alexander R.
(2014):
Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography.
In: Molecular Imaging, Bd. 13
[PDF, 945kB]